查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球手术敷料市场
市场调查报告书
商品编码
1380415

2023-2030 年全球手术敷料市场

Global Surgical Dressing Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

预计全球手术敷料市场在预测期内（2023-2030）将以CAGR6.4% 成长。腿部静脉溃疡、压疮和糖尿病足溃疡等慢性伤口的流行，给伤口护理专业人员带来了越来越大的挑战，对外科敷料行业的成长产生了相当大的影响。根据美国疾病管制与预防中心 (CDC) 的数据，超过 3,700 万美国人患有糖尿病，另外 9,600 万美国成年人患有糖尿病前期，这使他们面临 2 型糖尿病的风险。大约 25% 的糖尿病患者伤口癒合不良，这可能导致下肢被切除，并产生严重的经济和心理后果。高血糖环境会促进生物膜的生长，并使治疗糖尿病伤口变得困难。糖尿病可引起严重的併发症，包括心臟病、肾衰竭和失明。 2022年10月，根据澳洲卫生和老年护理部发布的报告，该部门在2019-2021年的三年内目标投资120万澳元用于伤口管理。慢性伤口在澳洲是一个严重问题，每年医院和住宅护理机构中估计有 40 万例慢性伤口。

此外，根据美国国立卫生研究院 (NIH) 的数据，慢性不癒合伤口 (CNHW) 通常与糖尿病、血管缺陷、高血压和慢性肾臟病等合併症有关。结果增加了对手术敷料的需求。此外，美国食品药物管理局 (FDA) 批准数量的增加也归因于手术敷料的日益普及。 2023 年4 月，3M Health Care 的创新3M (TM) Veraflo (TM) 疗法，包括3M (TM) Veraflo (TM) Cleanse Choice Complete (TM) 敷料和3M (TM) VAC Veraflo (TM) Cleanse Choice (TM ) 敷料，已收到首次获得美国食品药物管理局(FDA) 批准，可透过流体机械方式去除感染性物质、非活性组织和伤口碎片，从而减少所需的手术清创次数，同时促进肉芽组织形成，创造促进伤口癒合的环境。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • 3M Co.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • ConvaTec Group Plc
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Johnson & Johnson Services, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Smith & Nephew Plc
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按类型分類的全球手术敷料市场
    • 胶原蛋白敷料
    • 透明薄膜敷料
    • 海藻酸盐敷料
    • 泡棉敷料
    • 纱布敷料
    • 银敷料
    • 其他（水凝胶敷料、复合敷料）
  • 全球手术敷料市场（按应用）
    • 心血管疾病（CVD）
    • 糖尿病手术
    • 移植部位
    • 溃疡
    • 伯恩斯
  • 按最终用户分類的全球手术敷料市场
    • 医院
    • 门诊手术中心
    • 专科诊所
    • 家庭医疗保健

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • Abigo Medical AB
  • B. Braun SE
  • Baxter Healthcare Corp.,
  • Cardinal Health Inc.
  • Coloplast A/S
  • ConvaTec Group Plc
  • Derma Sciences Inc. (Integra LifeSciences)
  • Essity Aktiebolag AB,
  • Medline Industries Inc.
  • Medtronic Plc
  • Molnlycke Health Care AB
  • Molnlycke Health Care AB,
  • Narang Medical Ltd
  • Organogenesis Holdings Inc.,
  • Sanara MedTech, Inc.,
Product Code: OMR2027824

Title: Global Surgical Dressing Market Size, Share & Trends Analysis Report by Type (Collagen Dressings, Transparent Film Dressings, Alginate Dressings, Foam Dressings, Gauze Dressings, Silver Dressings, and Others), by Application (Cardiovascular Diseases (CVD), Diabetes Based Surgeries, Transplant Sites, Ulcers, and Burns), and by End-User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Home Healthcare)Forecast Period (2023-2030).

The global surgical dressing market is anticipated to grow at a CAGR of 6.4% during the Forecast Period (2023-2030). The prevalence of chronic wounds, such as venous leg ulcers, pressure ulcers, and diabetic foot ulcers, is increasing challenges to wound care professionals, having a considerable impact on the growth of the surgical dressing industry. According to the Centers for Disease Control and Prevention (CDC), more than 37 million Americans have diabetes, and another 96 million adults in the US have a condition called prediabetes, which puts them at risk for type 2 diabetes. About 25% of individuals with diabetes mellitus have poor wound healing, which can lead to the removal of lower limbs and has significant financial and psychological consequences. The hyperglycemic environment encourages the growth of biofilms and makes it challenging to treat diabetic wounds. Diabetes can cause serious complications, including heart disease, kidney failure, and blindness. In October 2022, according to the report published by the Australian Department of Health and Aged Care, the department made a targeted investment of $1.20 million over three years from 2019-2021 for wound management. Chronic wounds are a significant problem in Australia, with an estimated 400,000 cases in hospital and residential care settings yearly.

Furthermore, according to the National Institute of Health (NIH), chronic non-healing wounds (CNHW) are typically correlated with comorbidities such as diabetes, vascular deficits, hypertension, and chronic kidney disease. The result has increased the demand for surgical dressing. Furthermore, the rising number of food and drug administration (FDA) clearance also attributed to the increasing adoption of surgical dressing. In April 2023, 3M Health Care's innovative 3M™ Veraflo™ Therapy, with both 3M™ Veraflo™ Cleanse Choice Complete™ Dressing and 3M™ V.A.C. Veraflo Cleanse Choice™ Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue and wound debris which reduces the number of surgical debridement required, while promoting granulation tissue formation, creating an environment that promotes wound healing.

Segmental Outlook

The global surgical dressing market is segmented on the type, application, and end-user. Based on the type, the market is sub-segmented into collagen dressings, transparent film dressings, alginate dressings, foam dressings, gauze dressings, silver dressings, and others. Further, other types of surgical dressing include hydrogel dressings, composites dressings. Based on the application, the market is sub-segmented into cardiovascular diseases, diabetes-based surgeries, transplant sites, ulcers, and burns. Further, based on the end-user, the market is sub-segmented into hospitals, ambulatory surgery centers, specialty clinics and home healthcare. Among the type, the transparent film dressings sub-segment is anticipated to hold a considerable share of the market, owing to the maintaining wound moisture and reducing infection rates.

The Hospitals Sub-Segment is Anticipated to Hold a Considerable Share of the Global Surgical Dressing Market

Among the end-user, the hospitals sub-segment is expected to hold a considerable share of the global surgical dressing market. The segmental growth is attributed to the growing number of surgical procedures, increasing occurrence of diabetic foot ulcers, and rising number of hospitals. Hospitals provide services such as admitted patient care, including for elective surgery, emergency department care, and outpatient (non-admitted patient) care. As per the latest survey by the American Hospital Association (AH), the total number of hospitals in the US was counted ware 6,129 in 2023. Moreover, according to the Australian Institute of Health and Welfare, the number of hospitalizations in Australia has increased. In In 2021-22, there were 11.6 million hospitalizations, covering 31.8 million days of patient care, 59.0% (6.8 million) of hospitalizations were in public hospitals, accounting for 68.0.% of days of patient care (21.7 million). There are 41.0% (4.8 million) of hospitalizations were in private hospitals, accounting for 32.0% of days of patient care (10.0 million). Thus, with a growing number of hospitals, and hospitalization cases, the segment is projected to grow significantly over the forecast period.

Regional Outlook

The global surgical dressing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the increasing prevalence of diabetes, increasing R&D and growing medical tourism industry.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Surgical Dressing Market

Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. China dominates the Asia-Pacific surgical dressing market followed by India, Japan, South Korea, and the rest of the Asia-Pacific economies. The surgical dressing market in China is experiencing growth owing to rising number of surgeries, rising number of cardiovascular disease-related surgeries, and increasing prevalence of chronic disorders, such as diabetes. According to the World Health Organization, China has the highest number of diabetic patients globally, with nearly 116 million active cases in 2019, and is expected to increase to 150 million by 2040. The estimated diabetes prevalence rate in China in 2009 was 3.9% and is projected to increase to 5.4% by 2030. The prevalence of diabetes in Chinese adults aged 20-79 years is projected to increase from 8.2% to 9.7% during 2020-2030. The expansion and emergence of the wound care management sector by Chinese players such as Winner Medical, Covalon, and others contribute to the market's growth. For instance, in June 2022, Winner Medical displayed its latest and industry-leading advanced wound care solutions at the EWMA 2022 conference. At the conference, Winner Medical also launched a new product such as transparent film dressing, bordered silicone foam dressing with SAF and antibiosis series products and its new product, the CMC dressing. Winner Medical's wound care products have been widely used in more than 110 countries as primary solutions to provide wound management for acute and chronic wounds resulting from diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes.

Market Players Outlook

The major companies serving the global surgical dressing market include: 3M Co., ConvaTec Group Plc, Johnson & Johnson Services, Inc., Smith & Nephew Plc, Abigo Medical AB, B. Braun SE, Baxter Healthcare Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2022, Convatec Group Plc, a global medical solutions company focused on the management of chronic conditions, entered into a definitive agreement to acquire Triad Life Sciences Inc., a US-focused medical device company that develops biologically derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global surgical dressing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. 3M Co.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. ConvaTec Group Plc
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Johnson & Johnson Services, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Smith & Nephew Plc
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Surgical Dressing Market by Type
    • 4.1.1. Collagen Dressings
    • 4.1.2. Transparent Film Dressings
    • 4.1.3. Alginate Dressings
    • 4.1.4. Foam Dressings
    • 4.1.5. Gauze Dressings
    • 4.1.6. Silver Dressings
    • 4.1.7. Other (Hydrogel Dressings, Composites Dressings)
  • 4.2. Global Surgical Dressing Market by Application
    • 4.2.1. Cardiovascular Diseases (CVD)
    • 4.2.2. Diabetes Based Surgeries
    • 4.2.3. Transplant Sites
    • 4.2.4. Ulcers
    • 4.2.5. Burns
  • 4.3. Global Surgical Dressing Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Ambulatory Surgery Centers
    • 4.3.3. Specialty Clinics
    • 4.3.4. Home Healthcare

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abigo Medical AB
  • 6.2. B. Braun SE
  • 6.3. Baxter Healthcare Corp.,
  • 6.4. Cardinal Health Inc.
  • 6.5. Coloplast A/S
  • 6.6. ConvaTec Group Plc
  • 6.7. Derma Sciences Inc. (Integra LifeSciences)
  • 6.8. Essity Aktiebolag AB,
  • 6.9. Medline Industries Inc.
  • 6.10. Medtronic Plc
  • 6.11. Molnlycke Health Care AB
  • 6.12. Molnlycke Health Care AB,
  • 6.13. Narang Medical Ltd
  • 6.14. Organogenesis Holdings Inc.,
  • 6.15. Sanara MedTech, Inc.,

LIST OF TABLES

  • 1. GLOBAL SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL COLLAGEN DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL TRANSPARENT FILM DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL ALGINATE DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL FOAM DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL GAUZE DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL SILVER DRESSINGS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL OTHER TYPES OF SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLIACTION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SURGICAL DRESSING FOR CARDIOVASCULAR DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL SURGICAL DRESSING FOR DIABETES BASED SURGERIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL SURGICAL DRESSING FOR TRANSPLANT SITES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL SURGICAL DRESSING FOR ULCERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL SURGICAL DRESSING FOR BURNS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 16. GLOBAL SURGICAL DRESSING IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL SURGICAL DRESSING IN AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. GLOBAL SURGICAL DRESSING IN SPECIALTY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. GLOBAL SURGICAL DRESSING IN HOME HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 20. GLOBAL SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 24. NORTH AMERICAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 25. EUROPEAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 26. EUROPEAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 27. EUROPEAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 28. EUROPEAN SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 29. ASIA-PACIFIC SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 30. ASIA-PACIFIC SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 31. ASIA-PACIFIC SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 32. ASIA-PACIFIC SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 33. REST OF THE WORLD SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 34. REST OF THE WORLD SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 35. REST OF THE WORLD SURGICAL DRESSING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SURGICAL DRESSING MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL COLLAGEN DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL TRANSPARENT FILM DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL ALGINATE DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL FOAM DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL GAUZE DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL SILVER DRESSINGS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL OTHER TYPES OF SURGICAL DRESSING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL SURGICAL DRESSING MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 10. GLOBAL SURGICAL DRESSING FOR CARDIOVASCULAR DISEASES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL SURGICAL DRESSING FOR DIABETES BASED SURGERIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL SURGICAL DRESSING FOR TRANSPLANT SITES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL SURGICAL DRESSING FOR ULCERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL SURGICAL DRESSING FOR BURNS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL SURGICAL DRESSING MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 16. GLOBAL SURGICAL DRESSING IN HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL SURGICAL DRESSING IN AMBULATORY SURGICAL CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL SURGICAL DRESSING IN SPECIALTY CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 19. GLOBAL SURGICAL DRESSING IN HOME HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 20. GLOBAL SURGICAL DRESSING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 21. US SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. CANADA SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. UK SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. FRANCE SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. GERMANY SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. ITALY SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. SPAIN SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF EUROPE SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. INDIA SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. CHINA SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. JAPAN SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. SOUTH KOREA SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. REST OF ASIA-PACIFIC SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)
  • 34. REST OF THE WORLD SURGICAL DRESSING MARKET SIZE, 2022-2030 ($ MILLION)